1
Geenen, Joost W., Belitser, Svetlana, Vreman, Rick A., van Bloois, Martijn, Klungel, Olaf H., Boersma, Cornelis, Hovels, Anke M.
Veröffentlicht in: Geenen , J W , Belitser , S , Vreman , R A , van Bloois , M , Klungel , O H , Boersma , C & Hovels , A M 2020 , ' A novel method for predicting the budget impact of innovative medicines : validation study for oncolytics ' , European Journal of Health Economics , vol. 21 , no. 6 , pp. 845-853 . https://doi.org/10.1007/s10198-020-01176-x;
2020
Veröffentlicht in: Geenen , J W , Belitser , S , Vreman , R A , van Bloois , M , Klungel , O H , Boersma , C & Hovels , A M 2020 , ' A novel method for predicting the budget impact of innovative medicines : validation study for oncolytics ' , European Journal of Health Economics , vol. 21 , no. 6 , pp. 845-853 . https://doi.org/10.1007/s10198-020-01176-x;
2020
2
3
4
Boersma, Cornelis, Broere, Adriaan, Postma, Maarten J.
Veröffentlicht in: Boersma , C , Broere , A & Postma , M J 2010 , ' Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis ' , Value in Health , vol. 13 , no. 6 , pp. 853-856 . https://doi.org/10.1111/j.1524-4733.2010.00736.x;
2010
Veröffentlicht in: Boersma , C , Broere , A & Postma , M J 2010 , ' Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis ' , Value in Health , vol. 13 , no. 6 , pp. 853-856 . https://doi.org/10.1111/j.1524-4733.2010.00736.x;
2010
5
Geenen, Joost W., Boersmaz, Cornelis, Klungel, Olaf H., Hovels, Anke M.
Veröffentlicht in: Geenen , J W , Boersmaz , C , Klungel , O H & Hovels , A M 2019 , ' Accuracy of budget impact estimations and impact on patient access : a hepatitis C case study ' , European Journal of Health Economics , vol. 20 , no. 6 , pp. 857-867 . https://doi.org/10.1007/s10198-019-01048-z;
2019
Veröffentlicht in: Geenen , J W , Boersmaz , C , Klungel , O H & Hovels , A M 2019 , ' Accuracy of budget impact estimations and impact on patient access : a hepatitis C case study ' , European Journal of Health Economics , vol. 20 , no. 6 , pp. 857-867 . https://doi.org/10.1007/s10198-019-01048-z;
2019
6
Zakiyah, N., van Asselt, A. D. I., Postma, M. J.
Veröffentlicht in: Zakiyah , N , van Asselt , A D I & Postma , M J 2017 , ' Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands : cost minimization analysis and budget impact analysis ' , Journal of Medical Economics , vol. 20 , no. 3 , pp. 280-287 . https://doi.org/10.1080/13696998.2016.1254090;
2017
Veröffentlicht in: Zakiyah , N , van Asselt , A D I & Postma , M J 2017 , ' Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands : cost minimization analysis and budget impact analysis ' , Journal of Medical Economics , vol. 20 , no. 3 , pp. 280-287 . https://doi.org/10.1080/13696998.2016.1254090;
2017
7
van Boven JF, Kocks JWH, Postma MJ
Veröffentlicht in: International Journal of COPD, Vol Volume 11, Pp 2191-2201 (2016);
2016
Veröffentlicht in: International Journal of COPD, Vol Volume 11, Pp 2191-2201 (2016);
2016
8
van Schoonhoven, Alexander V., Schöttler, Marcel H., Serné, Erik H., Schrömbges, Patrick P.G., Postma, Maarten J., Boersma, Cornelis
Veröffentlicht in: van Schoonhoven , A V , Schöttler , M H , Serné , E H , Schrömbges , P P G , Postma , M J & Boersma , C 2023 , ' The health and budget impact of sodium-glucose co-transporter-2 inhibitors (SGLT2is) in The Netherlands ' , Journal of Medical Economics , vol. 26 , no. 1 , pp. 547-553 . https://doi.org/10.1080/13696998.2023.2194802;
2023
Veröffentlicht in: van Schoonhoven , A V , Schöttler , M H , Serné , E H , Schrömbges , P P G , Postma , M J & Boersma , C 2023 , ' The health and budget impact of sodium-glucose co-transporter-2 inhibitors (SGLT2is) in The Netherlands ' , Journal of Medical Economics , vol. 26 , no. 1 , pp. 547-553 . https://doi.org/10.1080/13696998.2023.2194802;
2023
9
de Jong, Lisa Aniek, van Schoonhoven, Alexander Victor, Hofstra, Hinko Stephan, Postma, Maarten Jacobus, van Hoek, Bart
Veröffentlicht in: de Jong , L A , van Schoonhoven , A V , Hofstra , H S , Postma , M J & van Hoek , B 2021 , ' Budget impact of optimizing rifaximin-alpha use for the prevention of recurrent hepatic encephalopathy in The Netherlands ' , Journal of Medical Economics , vol. 24 , no. 1 , pp. 1149-1163 . https://doi.org/10.1080/13696998.2021.1983291;
2021
Veröffentlicht in: de Jong , L A , van Schoonhoven , A V , Hofstra , H S , Postma , M J & van Hoek , B 2021 , ' Budget impact of optimizing rifaximin-alpha use for the prevention of recurrent hepatic encephalopathy in The Netherlands ' , Journal of Medical Economics , vol. 24 , no. 1 , pp. 1149-1163 . https://doi.org/10.1080/13696998.2021.1983291;
2021
10
Nicolas S. H. Xander, W. Edward Fiets, Carin A. Uyl-de Groot
Veröffentlicht in: Frontiers in Oncology, Vol 13 (2023);
2023
Veröffentlicht in: Frontiers in Oncology, Vol 13 (2023);
2023